These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 24588802)

  • 21. Efficacy of different dipeptidyl peptidase-4 (DPP-4) inhibitors on metabolic parameters in patients with type 2 diabetes undergoing dialysis.
    Park SH; Nam JY; Han E; Lee YH; Lee BW; Kim BS; Cha BS; Kim CS; Kang ES
    Medicine (Baltimore); 2016 Aug; 95(32):e4543. PubMed ID: 27512877
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interdialytic weight gain and survival in hemodialysis patients: effects of duration of ESRD and diabetes mellitus.
    Kimmel PL; Varela MP; Peterson RA; Weihs KL; Simmens SJ; Alleyne S; Amarashinge A; Mishkin GJ; Cruz I; Veis JH
    Kidney Int; 2000 Mar; 57(3):1141-51. PubMed ID: 10720966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypoglycemia-Related Hospitalizations and Mortality Among Patients With Diabetes Transitioning to Dialysis.
    Rhee CM; Kovesdy CP; You AS; Sim JJ; Soohoo M; Streja E; Molnar MZ; Amin AN; Abbott K; Nguyen DV; Kalantar-Zadeh K
    Am J Kidney Dis; 2018 Nov; 72(5):701-710. PubMed ID: 30037725
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of sitagliptin in patients with type 2 diabetes and ESRD receiving dialysis: a 54-week randomized trial.
    Arjona Ferreira JC; Corry D; Mogensen CE; Sloan L; Xu L; Golm GT; Gonzalez EJ; Davies MJ; Kaufman KD; Goldstein BJ
    Am J Kidney Dis; 2013 Apr; 61(4):579-87. PubMed ID: 23352379
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Continuous glucose monitoring in an end-stage renal disease patient with diabetes receiving hemodialysis.
    Narasaki Y; Park E; You AS; Daza A; Peralta RA; Guerrero Y; Novoa A; Amin AN; Nguyen DV; Price D; Kalantar-Zadeh K; Rhee CM
    Semin Dial; 2021 Sep; 34(5):388-393. PubMed ID: 34378258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unique hemoglobin A1c level distribution and its relationship with mortality in diabetic hemodialysis patients.
    Hoshino J; Larkina M; Karaboyas A; Bieber BA; Ubara Y; Takaichi K; Akizawa T; Akiba T; Fukuhara S; Pisoni RL; Saito A; Robinson BM
    Kidney Int; 2017 Aug; 92(2):497-503. PubMed ID: 28396123
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of Continuous Glucose Monitoring in the Assessment and Management of Patients With Diabetes and Chronic Kidney Disease.
    Ling J; Ng JKC; Chan JCN; Chow E
    Front Endocrinol (Lausanne); 2022; 13():869899. PubMed ID: 35528010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glycated albumin and risk of death and hospitalizations in diabetic dialysis patients.
    Freedman BI; Andries L; Shihabi ZK; Rocco MV; Byers JR; Cardona CY; Pickard MA; Henderson DL; Sadler MV; Courchene LM; Jordan JR; Balderston SS; Graham AD; Mauck VL; Russell GB; Bleyer AJ
    Clin J Am Soc Nephrol; 2011 Jul; 6(7):1635-43. PubMed ID: 21597024
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The combined diabetes and renal control trial (C-DIRECT) - a feasibility randomised controlled trial to evaluate outcomes in multi-morbid patients with diabetes and on dialysis using a mixed methods approach.
    Griva K; Rajeswari M; Nandakumar M; Khoo EYH; Lee VYW; Chua CG; Goh ZS; Choong YTD; Newman SP
    BMC Nephrol; 2019 Jan; 20(1):2. PubMed ID: 30606135
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antidiabetic Therapy in End-Stage Renal Disease.
    Boyle SM; Simon B; Kobrin SM
    Semin Dial; 2015; 28(4):337-44. PubMed ID: 25898790
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glycaemic control is a predictor of infection-related hospitalization on haemodialysis patients: Miyazaki Dialysis Cohort study (MID study).
    Toida T; Sato Y; Nakagawa H; Komatsu H; Kikuchi M; Uezono S; Yamada K; Ishihara T; Hisanaga S; Kitamura K; Fujimoto S
    Nephrology (Carlton); 2016 Mar; 21(3):236-40. PubMed ID: 26272229
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The management of terminal renal failure in diabetic patients by regular dialysis therapy.
    White N; Snowden SA; Parsons V; Sheldon J; Bewick M
    Nephron; 1973; 11(5):261-75. PubMed ID: 4753518
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of Hemodialysis and Peritoneal Dialysis on Glycometabolism in Patients with End-Stage Diabetic Nephropathy.
    Chen XX; Duan Y; Zhou Y
    Blood Purif; 2021; 50(4-5):506-512. PubMed ID: 33302273
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glycemic control and the risk of death in 1,484 patients receiving maintenance hemodialysis.
    Shurraw S; Majumdar SR; Thadhani R; Wiebe N; Tonelli M;
    Am J Kidney Dis; 2010 May; 55(5):875-84. PubMed ID: 20346561
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Glycemic Indices in Dialysis Evaluation (GIDE) study: Comparative measures of glycemic control in diabetic dialysis patients.
    Williams ME; Mittman N; Ma L; Brennan JI; Mooney A; Johnson CD; Jani CM; Maddux FW; Lacson E
    Hemodial Int; 2015 Oct; 19(4):562-71. PubMed ID: 25965145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dialytic therapy for diabetic patients with terminal renal failure.
    Miles AM; Friedman EA
    Curr Opin Nephrol Hypertens; 1993 Nov; 2(6):868-75. PubMed ID: 7922226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between glycemia and mortality in diabetic individuals on renal replacement therapy in the U.K.
    Adler A; Casula A; Steenkamp R; Fogarty D; Wilkie M; Tomlinson L; Nitsch D; Roderick P; Tomson CR
    Diabetes Care; 2014; 37(5):1304-11. PubMed ID: 24574356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term glycemic control measurements in diabetic patients receiving hemodialysis.
    Joy MS; Cefalu WT; Hogan SL; Nachman PH
    Am J Kidney Dis; 2002 Feb; 39(2):297-307. PubMed ID: 11840370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of glycemic status during the days of hemodialysis using dialysis solutions with and without glucose.
    Padmanabhan A; Velayudham B; Vijaykumar N; Allauddin S
    Saudi J Kidney Dis Transpl; 2018; 29(5):1021-1027. PubMed ID: 30381496
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hemodialysis and effect of corrective measures to prevent hypoglycemia.
    Katla V; Khyalappa R
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.